EGP-437

dexamethasone phosphate (ocular iontophoresis formulation) · Eyegate Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EGP-437, covering 2011-04-27 to 2018-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Iontophoretic Delivery of EGP-437 in Patients Who Have Undergone Cataract Surgery [Phase 2]